Peptic-tryptic-cotazym (PTC) digests were obtained, simulating in vivo protein digestion, from albumin, globulin, gliadin and glutenin preparations from hexaploid (bread) wheat a s well as from diploid (monococcum) and tetraploid (durum) wheat gliadins. The digest from bread wheat gliadins reversibly inhibited in vitro development and morphogenesis of small intestine from 17-day-old rat fetuses, whereas all the other digests (obtained both from nongliadin fractions and from gliadins from other wheat species) were inactive.
The PTC-digest from bread wheat gliadins was also able to prevent recovery of and to damage the in vitro cultured small intestinal mucosa from patients with active coeliac disease (gluteninduced entheropathy). The PTC-digest from durum wheat gliadins caused a much less adverse effect on this human pathologic tissue culture system.
Speculation
When tested with different in vitro systems, bread wheat gliadin peptides active in coeliac disease displayed several peculiar biologic activities including an immunogenic character in susceptible individuals (Z), a probable immunomediated cytotoxic activity on small intestinal mucosa specimens from coeliac patients (6-10, 13-15, 17) , and a probable direct cytotoxic activity on developing rat fetal intestine (5) . In fact, these peptides induce the following: (I) proliferation of peripheral blood lymphocytes from coeliac patients as well as from many first degree relatives of coeliacs and from only a few normal controls; (2) damage of the in vitro cultured small intestinal mucosa of patients with active coeliac disease; and (3) reversible inhibition of the in vitro development of fetal rat intestine.
Although no one of the mentioned in vitro systems can be considered a model fully representative of coeliac disease, it is likely that each one of them highlights a different important feature underlying the appearance of the small intestine lesion in coeliac patients ingesting bread wheat gliadin peptides.
Peptide mixtures obtained by enzymic digestion of the gliadin fraction from hexaploid (bread) wheats significantly differ from those from tetraploid (durum) wheat gliadins for their higher toxicity toward cultures of intestine from rat fetuses or coeliac children. However, gliadin peptides from both bread and durum wheats are capable of inducing proliferation of peripheral blood lymphocytes from coeliac patients thus suggesting a similar immunogenic character (2) .
We suggest that durum wheat gliadins peptides are in vitro less toxic than bread wheat gliadins peptides for the small intestinal mucosa of coeliacs as they have less direct cytotoxic effect on the enterocyte; moreover, durum wheat products (e.g., spaghetti), a s compared to bread wheat products (e.g., bread and biscuits), might present a lower risk for patients suffering for coeliac disease or other wheat intolerances.
The detection and characterization of wheat components that are toxic in coeliac disease and in other forms of wheat intolerance (5) is very difficult because of the lack of suitable in vitro methods for toxicity testing.
Falchuk et al. (6, 7) have proposed the organ culture of human small intestinal biopsies as an in vitro model of coeliac disease. Jejunal specimens obtained from patients with active enteropathy shows morphological and biochemical improvement when cultured in a gluten-free medium. No improvement occurs when the tissue is cultured in the presence of gluten peptides. Several other authors (10, 13, 14, 15) have confirmed Falchuk et aL's findings, although Haury et al. (1 1) were not able to show a cytotoxic effect of various gluten preparations on organ culture of small intestinal mucosa from coeliac children. Jejunal mucosa from coeliac patients in remission and from normal subjects is not affected by the presence of gluten in the culture medium. These findings led Falchuk et a[. to suggest that gluten must first initiate a set of events in vivo, possibly related to the immune system (8, 9) , before the cytotoxic effect on enterocytes can be displayed in vitro.
In 1976 we undertook a research program to evaluate whether the in vitro developing intestine from rat fetus may offer a model for the study of proteins and peptides toxic for the intestinal mucosa in some pathologic conditions resulting in the presence of immature enterocytes on the surface of the human mucosa. This typical feature also characterizes some stages underlying maturation of rat fetal intestine, which takes place in vitro, in a way comparable to what happens in vivo (4) . We have previously demonstrated (5) that a peptic-tryptic-pancreatic digest of hexaploid (bread) wheat gliadin, obtained by stimulating in vivo protein digestion, was very active in inhibiting in vitro development and morphogenesis of small intestine from 17-and 18-day old rat fetuses. It had no effect on the culture of jejunum from 21-day old fetuses or from newborn rat; moreover, this digest induced extensive tissue degeneration and necrosis of in vitro cultured small intestinal mucosa from patients with active coeliac disease, but did not cause any detectable effect on normal human small intestinal mucosa.
This paper deals with further investigations we have carried out on this topic. As a first point we studied the reversibility of the inhibiting effect of the PTC-digest of bread wheat gliadin on in vitro development and morphogenesis of small intestine from rat fetus. We tested peptides obtained with an identical digestion procedure by several other protein fractions from bread wheat (including albumins, globulins and glutenins) as well as a tryptic fragment of Hekkens' a-gliadin to see whether they display similar toxic effects. Wheat seed endosperm contains heterogeneous protein classes usually divided, according to their extractability and solubility in different solvent systems, into albumins, globulins, gliadins and glutenins. Albumins and globulins are extracted in neutral salt solutions of low and high ionic strengths respectively, whereas gliadins are alcohol-soluble and glutenins require acidic or alkaline solutions of low ionic strength to be extracted (16) . Gliadins are most deficient in the essential amino acid lysine and are characterized by a very high content of glutamine (one residue each three amino acid residues) and proline (one residue each seven amino acid residues).
Finally, we have continued previous experiments with both cultured fetus rat jejunum and small intestinal mucosa from coeliac children with active disease in order to assess whether wheat species other than bread hexaploid wheats (e.g., tetraploid and diploid wheats) also contain toxic amino acid sequences in their gliadin fractions.
MATERIALS AND METHODS
A tryptic fragment of purified a-gliadin prepared according to Hekkens et al. (12) was generously supplied by Dr. W.Th.J.M. Hekkens. Pure bread (Mentana and San Pastore), durum (Azizia and Cappelli) and monococcum varieties were kindly supplied by the Istituto Sperimentale per la Cerealicoltura in Roma. Bread (Triticum aestivum) wheat varieties are hexaploid (AABB DD), durum (Triticum durum) wheat varieties tetraploid (AA BB) and monococcum (Triticum monococcum) varieties are diploid (AA) (1 8).
For preparation of the globulin fraction, 100 g of finely ground whole wheat flour was extracted at 4OC for 3 h in a shaker with 1 liter of a 0.04 M Na2HP04 (pH 7) buffer containing 1.8 M (NH4)2S04. After extraction, the suspension was centrifuged for After 48 h culture: a) without peptides (50) b) PTC gliadin from hexaploid wheat (Mentana)3 0. I mg/ml (10) 0.5 mg/ml (8) c) PTC gliadin from hexaploid wheat (San Pastore) 0.1 mg/ml (6) 0.5 mg/ml (6) d) PTC gliadin from tetraploid wheat ( A~i z i a )~ 0.1 mg/ml (10) 0.5 mg/ml (8) e) PTC gliadin from tetraploid wheat (Cappelli) 0.1 mg/ml (6) 0.5 mg/ml (6) f) PTC gliadin from diploid wheat (Monococco) 0.1 mg/ml (10) 0.5 mg/ml (10) PTC albumins from hexaploid wheat (Mentana) 0.1 mg/ml (2) 0.5 mg/ml (2) PTC globulins from hexaploid wheat (Mentana) 0.1 mg/ml (2) 0.5 mg/ml (2) PTC glutenins from hexaploid wheat (Mentana) 0.1 mg/ml (2) 0.5 mg/ml (2) ' Number of fetuses examined or number of fetal jejunums cultured in parenthesis.
' * Indicated slight degenerative changes; ++ indicates large necrotic areas.
The following peptides mixtures were used: (total) PTC protein digest in 12 cultures and peptide fraction with molecular weight 2,000-10,000 in six cultures.
The following peptide mixtures were used: (Total) PTC protein digest in 8 cultues, peptide fraction with molecular weight 2,000-10,000 in six cultures and with molecular weight 5,000-10,000 in four cultures.
15 min at 16,000 x g. The supernatant was dialyzed against distilled water for 48 h at 4OC to obtain the globulin fraction as a precipitate. Identical experimental conditions were applied with other solvents for the consecutive extractions of the albumin, gliadin and glutenin fractions from the residue from the first extraction. The extraction solvent of albumins was 0.04 M Na2HP04(pH 7) containing 0.4 M (NH4)2S04, that for extraction of gliadins was ethanol: water (70:30 v/v), and for the extraction of glutenin 0.1 M acetic acid was used. Gliadin and glutenin fractions were extracted at room temperature using 300 ml of solvent for 100 g of flour.
The procedure for gliadin preparation used here is significatively different from that previously used by de Ritis et al. (5) who extracted gliadins from commercial wheat gluten instead of from wheat flour.
Peptic-tryptic-cotazym (PTC) digests were prepared from wheat protein fractions following the three step procedure of Bronstein et al. (3) as reported by de Ritis et al. (5) . One hundred g of protein fraction was digested in 1 liter of 0.2 N HC1 (pH 1.8) with 2 g of purified pepsin at 37°C for 2 h. The peptic digest was further digested by addition of 2 g of purified trypsin after pH adjustment to 8.0 with 2 N NaOH. The reaction mixture was vigorously stirred at 37°C for 4 h at pH 8.0. Then, the peptictryptic digest was treated with 2 g of purified cotazym and mechanically stirred for 2 h at pH 8.0. During all the digestion procedure the pH was checked periodically and, when needed, adjusted with HCl or NaOH. At the end of the whole digestion procedure, the digest was submitted to gel filtration and the peptide fractions eluted after cytochrome c were collected and freeze-dried. These enzyme-free low-molecular-weight peptide pools have been coded as PTC protein digest.
Lyophilized PTC from Mentana hexaploid wheat and Azizia tetraploid wheat, were redissolved in water and submitted to ultrafiltration in an Amicon 400 milliliter cell equipped with UM 2 Amicon membrane to remove compounds with molecular weights lower than 2,000 and to obtain a peptide fraction with molecular weight in the range 2,000-10,000. Then this fraction was submitted to ultrafiltration using a DM5 Amicon membrane to prepare peptide subfraction with molecular weights in the range 5,000-10,000.
For in vitro culture of fetal jejunum, time-pregnant Wistar rats were anesthetized with ether and 17-day-old fetuses were removed at laparatomy. Fetal jejunum segments were isolated and cultured in vitro for 48 h in a serum-free medium, according to the method described by de Ritis et al. (4) . Jejunal segments from the same fetus were cultured in the absence and in the presence of tested peptides. Differentiation of the fetal rat jejunum was followed morphologically by light microscopy as reported by de Ritis et al. (4) .
For in vitro culture of human small intestinal mucosa, intestinal biopsies were obtained at the duodenojejunal flexure from 37 children affected by active coeliac disease, with subtotal mucosal atrophy; of these 26 had never been treated before, 11 were in relapse after the reintroduction of gluten in the diet since at least 5 months. Diet of biopsied children contained both durum (spaghetti and other pasta products) and bread wheat products (bread and biscuits). The biopsies were cultured for 48 h in a serum containing medium, with or without added peptides and then processed for morphological examination by light microscopy, as reported by de Ritis et al. (5) . Seven out the 37 children with active coeliac disease were also examined for the histocompatibility antigens. Four were cultured with hexaploid and three with tetraploid gliadin peptides: they were either HLA-DR W7 or HLA-DR W3 positive.
RESULTS

Culture of fetal rat intestine.
Before in vitro culture, jejunal segments from 47 17-day-old rat fetuses did not show any villus. Only undifferentiated cuboidal stratified epithelia lining the lumen were present: in three other fetuses few very rudimentary villi with monostratified epithelial cells were observed (Table 1 and Fig. la) . No goblet cells could be detected at this stage of tissue development. After 48-h of in virro culture without added wheat peptides (Table 1 and Fig. Ib) , there was clear morphologic evidence of tissue maturation in 48 cultured fetal jejunum out of a total of 50. Well differentiated villi were present in cultured jejunal segments from as many as 43 fetuses and rudimentary villi were observed in the specimens from five other fetuses. In 49 fetuses, the epithelial lining consisted exclusively of simple columnar epithelium and in 22 cases goblet cells were identified. Patchy, slightly degenerative changes characterized by a decreased cytoplasmic staining, nuclear pycnosis and large lysosomelike inclusions were observed only in a few cultured jejunal segments from 12 fetuses. These findings confirm previous results by de Ritis et al. (4, 5) , showing that differentiation and maturation of small intestinal mucosa from rat fetuses takes place in vitro in a way comparable to what happens in vivo.
The peptic-tryptic-cotazym digests of the gliadin fractions from two varieties (Mentana and San Pastore) of hexaploid bread wheat, and the 2,000-10,000 peptide fraction of the PTC digest from Mentana gliadins were very active in slowing down in vitro development of fetal rat intestine and in increasing occurrence and severity, especially at the mesenchyme level, of degenerative changes sporadically observed in the control tissue (Table 1 and Fig. Ic) . Such effects were also clearly observed at the lowest peptide concentration tested (0.1 mg/ml of incubation medium). After 48 h of culture, well differentiated villi were absent in all cultures. Villi were rudimentary in one case and absent in 29 cases; moreover, the epithelium was monostratified in all the cases, but it was cuboidal in 11 cases and goblet cells were absent in all cultures. These results are very similar to those obtained by de Ritis et al. (5) who tested a PTC digest of the gliadin fraction prepared with a different procedure from commercial gluten. When tested under identical experimental conditions, the tryptic fragment of a-gliadin fraction prepared according to Hekkens et al. (12) showed, at a concentration of 0.1 mg/ml of culture medium, a comparable activity in interfering with the process of in vitro maturation and differentiation of fetal rat intestine. On the contrary PTC digests from bread wheat albumins, globulins, and gluten~ns showed no one of the effects induced by gliadin digest from bread wheat and were practically inactive (Table 1) . The reversibility of the effect of PTC gliadin digest from bread wheat was shown by the fact that, after an initial 24 h culture in a medium added with the digest of bread wheat gliadin, the intestinal mucosa underwent a normal morphogenesis when transferred to a gliadin peptide-free culture medium. In fact, when jejunal segments from three fetuses were cultured in the presence of peptides (0.5 mg/ml of culture medium), villi were absent. The villi developed in all cases with a cylindrical epithelium after 24 h when the culture medium had been substituted with a medium free from wheat peptides (Fig. 2) .
In contrast to what was observed with bread wheat, the PTC digests of gliadins from two varieties (Azizia and Cappelli) of durum tetraploid wheat as well as the 2,000-10,000 and 5,000-10,000 peptide fractions did not affect in vitro development and morphogenesis of fetal rat jejunum, even when they were tested at a concentration as high as 0.5 mg/ml (Table 1 and Durum wheat gliadin peptides did not afford any protection of rat fetal intestine against toxicity of bread wheat gliadin peptides. In fact, no maturation and differentiation was observed when intestine specimens from two rat fetuses were cultured in the simultaneous presence of equal concentrations (0.25 mg/ml of medium) of peptides from both bread (Mentana) and durum (Azizia) gliadins.
Culture of small intestinal biopsies of children with active coeliac disease. Before in vitro culture, all the small intestinal biopsy specimens from 37 children showed a flat mucosa with total loss of villous pattern and elongated hypertrophic crypts. The surface epithelium showed cuboidal cells with irregular nuclei and increase of intraepithelial lymphocytes (Fig. 3a) . After 48 h culture with no added wheat peptides, all these biopsies showed significant recovery with an almost complete disappearance of the morphologic abnormalities of the surface epithelium (Fig. 3b) . Enterocytes were taller with basally oriented oval nuclei and the lymphocytes were reduced. Moreover, in some areas, very short villi could be observed after culture.
Biopsy specimens from children with coeliac disease did not recover when cultured for 48 h in the presence of 0.5 mg of PTC gliadin digest from bread wheat per ml culture medium. Furthermore, a severe mucosal damage was evident in 12 out of 13 cultures tested including five cultures with extensive necrotic areas (Fig. 3c) . Impairment was also observed in two biopsies cultured in the presence of 0.1 mg/ml of medium of the tryptic fragment of a-gliadin fraction prepared according to Hekkens (12) . On the contrary, at the concentration of 0.5 mg/ml of culture medium, the PTC digest of gliadin fraction from durum (var. Azizia) wheat, did not inhibit in vitro occurring epithelial recovery in 12 out of 19 flat biopsies and caused no change in six other cases (Fig. 4) . In only one case a damaging effect of these peptides on flat coeliac mucosa was observed. Even when tested at a concentration of 1 mg/ml, the PTC digest of durum gliadins caused no change in two small intestinal biopsies, but, at a concentration of 2.5 mg/ml, this digest induced a significant mucosal damage in all the three biopsies tested (Table 2) .
DISCUSSION
The data reported in this paper confirm previous findings by de Ritis et al. ( 5 ) showing that gliadins from bread (hexaploid) wheats contain amino acid sequences capable of inhibiting in vitro development and morphogenesis of jejunum from the 17-day-old rat fetus as well as epithelial recovery of cultured specimens of flat intestinal mucosa from active coeliac patients. These amino acid sequences persist in peptides formed during in vitro digestion of bread wheat gliadins under experimental conditions simulating in vivo protein digestion. The inhibitory effect of the PTC gliadin digest from bread wheat on rat fetal intestine is reversible and not common to any other protein fraction from bread wheat.
It was somewhat surprising to find out that, under in vitro conditions, peptides from durum wheat gliadins, although not harmless, are much less toxic than those from bread wheat gliadins for both human and rat intestines. This was shown by the absence of adverse effects of durum wheat peptides on rat fetal intestine at the highest tested concentration and by the fact that, as compared to bread wheat peptides, a 5-fold higher concentration of durum wheat peptides is necessary to induce impairment, but not yet extensive necrosis, in cultures of mucosa specimens from coeliac children. If these in vitro findings also apply to in vivo conditions, they would indicate that durum wheat, although not harmless, could be much better tolerated than bread wheat in coeliac disease. As a matter of fact preliminary clinical data concerning a few coeliac children in remission who ingested for several months durum wheat products, indicate that durum wheat is also able to cause atrophy of duodenal mucosa (1). However, only a very extensive clinical trial of durum wheat foods (spaghetti and other pasta products) can show whether durum wheat food present, as compared to bread wheat foods (bread, biscuits and other products), a lower risk for coeliac patients or for patients suffering for other wheat intolerances. In our opinion, the possibility that durum wheat is better tolerated than bread wheat by humans under some special circumstances deserves thorough attention.
